AAV Rep78 Suboptimal Initiation Codon for Stable Insect Cell Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing adeno-associated viral vectors (AAV) in mammalian cells face challenges such as low yield and contamination risks, making large-scale production for clinical use difficult, while insect cell systems require modifications to achieve correct stoichiometry of capsid proteins and suffer from instability in Rep protein expression.
Innovation Solution
The use of a nucleotide sequence encoding animal parvoviral Rep proteins with a suboptimal initiation codon for Rep78, combined with expression control sequences and a baculovirus expression system, to achieve stable and high-yield production of AAV vectors in insect cells by optimizing the molar ratio of Rep78 to Rep52 proteins and improving vector stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If mammalian cell culture systems are used for AAV production, then the ability to sustain AAV replication is improved, but the productivity and scalability are worsened due to low yield per cell and contamination risks
Solution Approach 1:
The patent uses insect cells as an intermediary host system that can be infected by baculovirus expressing AAV Rep proteins, thereby enabling AAV replication without using mammalian cells. This intermediary approach maintains AAV replication capability while avoiding the limitations of mammalian cell systems, achieving higher productivity and eliminating contamination risks associated with mammalian cell culture
Solution Approach 2:
The patent modifies the initiation codon of the Rep78 gene from the optimal ATG to suboptimal codons (ACG, TTG, CTG, or GTG), which changes the translation initiation parameters. This parameter change results in improved stability of Rep protein expression in insect cells and higher overall AAV production yield, resolving the contradiction between replication capability and productivity
2Productivity
If insect cell systems are used for AAV production, then the productivity and scalability are improved, but the stability of Rep protein expression is worsened
Solution Approach 1:
The patent changes the initiation codon parameter of the Rep78 gene from optimal (ATG) to suboptimal (ACG, TTG, CTG, or GTG). This parameter change adapts the gene expression to insect cell physiology, resulting in stable Rep protein expression across multiple passages while maintaining high productivity and scalability for large-scale AAV production
3Productivity
If optimal initiation codon (ATG) is used for Rep78 translation, then the translation efficiency is improved, but the stability of Rep protein expression in insect cells is worsened
Solution Approach 1:
The patent modifies the initiation codon parameter from ATG (optimal) to suboptimal codons (ACG, TTG, CTG, or GTG). This parameter change reduces translation initiation efficiency slightly but dramatically improves the stability of Rep protein expression in insect cells, likely by preventing premature termination or degradation, thereby achieving more stable and sustained protein production
Data Source
AI summary
The present invention relates nucleic acid constructs for the production of recombinant parvoviral (e.g. adeno-associated viral) vectors in insect cells, to insect cells comprising such constructs and to methods wherein the cells are used to produce recombinant parvoviral virions. The insect cells preferably comprise a first nucleotide sequence encoding the parvoviral rep proteins whereby the initiation codon for translation of the parvoviral Rep78 protein is a suboptimal initiation codon that effects partial exon skipping upon expression in insect cells. The insect cell further comprises a second nucleotide sequence comprising at least one parvoviral (AA V) inverted terminal repeat (ITR) nucleotide sequence and a third nucleotide sequence comprising a sequences coding for the parvoviral capsid proteins.